Top 21 Prilenia investors
The most complete profiles first. Showing 21 of 21.
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Anastasia KarpovaVerified
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Catherine PoulinVerified
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Geert
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor · Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Juliette Audet
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Alain J. Gilbert
Private Equity Firm, Investment Partner · France
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Asiya Giniatullina
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Bonnie van Wilgenburg
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Marc
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Sander van Deventer
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Matt BennettVerified
Venture Capital · United States
Health CareWomen FoundedNetwork HardwareNews MediaPortfolio: Bond Vet, ChinaWeb, Prilenia, qServe Communications
Verified email available
Blane Walter
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedNetwork HardwareNews MediaPortfolio: Bond Vet, ChinaWeb, Prilenia, qServe Communications
Contact details available
George Bennett
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedNetwork HardwareNews MediaPortfolio: Bond Vet, ChinaWeb, Prilenia, qServe Communications
Contact details available
Matt Walter
Venture Capital · United States
Health CareWomen FoundedNetwork HardwareNews MediaPortfolio: Bond Vet, ChinaWeb, Prilenia, qServe Communications
Contact details available
By investment stage
- Seed7
By location
Related industries
Most-backed portfolio companies
- BioVex17
- Fovea Pharmaceuticals14
- Pieris AG14
- NeRRe Therapeutics14
- Inflazome14
- Achilles Therapeutics14
- Argos Therapeutics14
- ACADIA Pharmaceuticals14
- Ardana Bioscience14
- CircuLite14
- NovoGI14
Frequently asked questions
How many Prilenia investors are on Angel Roster?
Angel Roster lists 21 Prilenia investors. 5 of them (24%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (11) and Investment Partner Investors (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Prilenia investors invest in?
Among those that list a stage, the most common are Seed (7).
Where are Prilenia investors based?
Most are based in the Netherlands (12), the United States (4) and Canada (2).
Which companies have Prilenia investors backed?
The most-backed portfolio companies among them are BioVex (17), Fovea Pharmaceuticals (14), Pieris AG (14), NeRRe Therapeutics (14) and Inflazome (14).
How do I contact Prilenia investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.